The Therapeutic Effect of Intracerebral Transplantation of SPIO and EGFP Double Labeled GDNF Gene Modified Mesencephalic Neural Stem Cells in Rat Model of Parkinson's Disease

邓兴力,王应莉,杨智勇,李向新,龙江,雷德强,刘如恩,冯忠堂
DOI: https://doi.org/10.19845/j.cnki.zfysjjbzz.2010.02.003
2010-01-01
Abstract:Objective To explore the therapeutic effect of intracerebral transplantation of superparamagnetic iron oxide(SPIO) and enhanced fluorescence protein(EGFP) double labeled glial cell line derived neurotrophic factor(GDNF) gene modified embryonic mesencephalic neural stem cells(mNSCs) in rat model of Parkinson's disease(PD).Methods The PD rats were randomly devided into control group,GFP gene modified mNSCs transplantation group and GDNF gene modified mNSCs transplantation group.Respective cells were stereotaxic injected into APO induced rotational behavior test was performed to evaluate the therapeutic effect of cell transplantation.MRI scan and immunofluorescence histochemistry were conducted to identify the distribution and differentiation of transplantated cells.Results Compared with other groups,transplantation of GDNF gene modified mNSCs had the most striking therapeutic effect.Almost all cells were stayed in situ,not migrating out of transplantation area.Most mNSCs kept undifferentiated state or differentiated into glial cells,only very few cells could differentiate into DA neurons.Compared with other groups,there were more mNSCs differentiated into DA neurons in GDNF gene modified mNSCs transplantation group.Conclusions MRI detection of SPIO labeled cells is a promising method to analysis the cells following intracerebral transplantation.Intracerebral transplantation of SPIO and EGFP double labeled GDNF gene modified mNSCs can significantly improve abnormal behavior of PD rats.However,further research is needed to explore the mechanism of cell transplantation for PD.
What problem does this paper attempt to address?